Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

In Guatemala, social worker Eduardo Canuz fights logistical and cultural challenges while preventing women and infants from inhaling smoke.

While the country has made great strides in controlling AIDS and other infectious diseases, Kenyans are living longer and chronic diseases such as diabetes, heart disease and cancer are on the rise.

The molecule restores the activity of neurons and neural circuits in a model of the disease.

A Novartis experimental drug in clinical trial aims to block liver cancer growth

The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.

Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.

An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.